Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HLA-DRA |
| Upstream (Parents) |
|---|
| (<<) HLA-DQA2///HLA-DQA1 → HLA-DRA |
| (<<) CTSS → HLA-DRA |
| (<<) HLA-DRB6 → HLA-DRA |
| (<<) HLA-DRB1 → HLA-DRA |
| Downstream (Children) |
|---|
| HLA-DRA → TNFSF12-TNFSF13///TNFSF12///TNFSF13 (>>) |
| HLA-DRA → LOC440122 (>>) |
| HLA-DRA → APOL4 (>>) |
| HLA-DRA → CD84 (>>) |
| HLA-DRA → CD40 (>>) |
| HLA-DRA → TYROBP (>>) |
| HLA-DRA → MYO10 (>>) |
| HLA-DRA → HLA-DQA2///HLA-DQA1 (>>) |
| HLA-DRA → SRGN (>>) |
| HLA-DRA → CD52 (>>) |
| HLA-DRA → CD74 (>>) |
| HLA-DRA → APOC1 (>>) |
| HLA-DRA → CTSS (>>) |
| HLA-DRA → TMEM176B (>>) |
| HLA-DRA → LY96 (>>) |
| HLA-DRA → AIF1 (>>) |
| HLA-DRA → SH3BGRL (>>) |
| HLA-DRA → HLA-DRB1 (>>) |
| HLA-DRA → LST1 (>>) |
| HLA-DRA → BMP2K (>>) |
| HLA-DRA → ENTPD1 (>>) |
| HLA-DRA → GYPC (>>) |
